FluxMPS™ William's Medium E: 1X Liquid
FluxMPS™ DCP-WME1X is a Microfluidics Suitable, quadruple-stage ultra-filtered William's Medium E formulation engineered for primary hepatocyte, liver-on-chip, and hepatoma cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. Processed through a Quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used in conventional sterile filtration. Formulation: [+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (2 g/L), [+] Sodium Pyruvate.
- Glucose held at 2000 mg/L (2.0 g/L) — a physiologically appropriate, low-glucose level for primary hepatocyte metabolism
- Glutathione (reduced), 0.050 mg/L — antioxidant support for redox-sensitive hepatocyte culture
- Methyl linoleate (fatty acid), 0.030 mg/L — supports hepatocyte lipid metabolism and CYP450 function
- Quadruple-stage filtration: 0.1 µm prefiltration I → 0.04 µm final filtration I → 0.1 µm prefiltration II → 0.04 µm final filtration II (polish)
- Endotoxin release specification: < 0.05 EU/mL (USP <85>, LAL), tested per manufacturing batch
- Ultrapure Type 1 water (18.2 MΩ·cm) with controlled trace metals and low TOC; manufactured under an ISO 13485:2016 quality management system
- 51 ingredients across Inorganic Salts, Amino Acids, Vitamins and Others — full composition and CAS numbers below
- pH, salts, HEPES and nutrient composition available on request — contact support@diagnocine.com
- Media familyWilliam's Medium E
- Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (2 g/L), [+] Sodium Pyruvate
- Glucose2000 mg/L (2.0 g/L)
- AppearanceOrange-red colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)Contact for specification
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
Conventional 0.22 µm–filtered William's Medium E can pass mycoplasma, subvisible particulates, and endotoxin fragments that disrupt primary hepatocyte function and bile canaliculi formation. FluxMPS™ is engineered to reduce these risks.
Microchannel-safe purity
0.04 µm final filtration and USP <788> particulate compliance support particle-free delivery, preserving bile canaliculi geometry in liver-on-chip models.
Hepatocyte-optimized formulation
William's Medium E contains methyl linoleate (fatty acid) and reduced glutathione, supporting primary hepatocyte lipid metabolism and antioxidant defense.
Ultrapure-grade water
Type 1 water (18.2 MΩ·cm) with controlled trace metals and low organic carbon (TOC) supports consistent, reproducible hepatocyte culture performance batch to batch.
Low-endotoxin release specification
< 0.05 EU/mL (USP <85>, LAL assay), tested per manufacturing batch — helps reduce the risk of LPS-driven Kupffer cell activation in hepatocyte co-culture models.
Rich, hepatocyte-specific nutrient profile
A specialized amino acid, vitamin, fatty acid, and antioxidant profile for demanding hepatocyte-derived cell types — delivered particle-free for OoC use.
Customization on demand
pH, nutrient concentrations, HEPES, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two dedicated prefilter/final-filter pairs — reaching a final 0.04 µm polish.
-
1
0.1 µm Prefiltration I
Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; 0.1 µm-and-larger mycoplasma-retentive filtration and retention of sub-micron particulates/microaggregates that pass a 0.22 µm filter.
-
3
0.1 µm Prefiltration II
A second, dedicated prefilter protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish.
Performance vs. conventional media
FluxMPS™ DCP-WME1X is processed through a quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used in conventional sterile filtration — with 0.1 µm mycoplasma-retentive filtration applied at every production stage.
© Diagnocine® — DCP-WME1X
Hepatocyte and liver OoC applications
FluxMPS™ DCP-WME1X — William's Medium E — delivers 0.04 µm filtered purity for primary hepatocyte and related OoC applications.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) MPS Grade, ultra nano-filtered variant of this formulation is available on request for automated bioreactors and robotic liquid-handling systems.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates the 0.04 µm Microfluidics Suitable tier does not target
- Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion systems
- Extended Perfusion Stability: Supports consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Primary Hepatocyte Culture
William's Medium E is a standard base for primary hepatocyte culture — methyl linoleate and glutathione support CYP450 activity and albumin synthesis.
Liver-on-Chip
0.04 µm filtered William's Medium E delivers fatty acid (methyl linoleate) and antioxidant (glutathione) support for liver-on-chip and hepatocyte OoC bile canaliculi models.
Hepatotoxicity Assays
A standard base for in vitro hepatotoxicity screening — CYP450 induction, drug metabolism, and bile acid transport assays.
Hepatoma Cell Lines
Supports Huh-7, HepG2, and HepaRG hepatoma lines in differentiation protocols and viral hepatitis models.
Hepatocyte Metabolic Studies
Low glucose (2 g/L) plus methyl linoleate supports fatty acid oxidation, lipid metabolism, and hepatic metabolomics assays.
Low background for imaging
Ultra-low particulate filtration (0.04 µm) reduces particulate interference in hepatocyte confocal microscopy and TEER-monitored liver-on-chip assays. This formulation contains phenol red; a phenol red–free variant is available on request for optical background–sensitive imaging applications.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] Calcium, [+] Magnesium, [+] Glucose (2 g/L), [+] Sodium Pyruvate |
| Appearance | Orange-red colored, clear solution |
| Glucose | 2000 mg/L (2.0 g/L) |
| L-Glutamine | 292.000 mg/L |
| Sodium Pyruvate | 25.000 mg/L |
| Phenol Red | 10.700 mg/L |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | Contact for specification |
| Total ingredients | 51 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | This formulation's sodium bicarbonate content (80 mg/L; ≈1 mM) is substantially below the level used in standard 5% CO2-buffered media, implying near-atmospheric CO2 buffering capacity. Validate CO2 tension empirically for your protocol, or contact support@diagnocine.com for a bicarbonate-adjusted formulation. |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
William's Medium E: 51 ingredients verified per lot with CAS numbers for full raw-material traceability. William's Medium E contains methyl linoleate (fatty acid) and glutathione supporting primary hepatocyte lipid metabolism and antioxidant defense.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Copper sulfate pentahydrate | 7758-99-8 | 0.0001 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.0001 |
| Manganese chloride tetrahydrate | 13446-34-9 | 97.670 |
| Magnesium sulfate anhydrous | 7487-88-9 | 0.0001 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 80.000 |
| Sodium chloride | 7647-14-5 | 6000.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Zinc sulfate heptahydrate | 7446-20-0 | 0.0002 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 50.000 |
| L-Alanine | 56-41-7 | 90.000 |
| L-Arginine hydrochloride | 1119-34-2 | 60.460 |
| L-Asparagine monohydrate | 5794-13-8 | 20.000 |
| L-Aspartic acid | 56-84-8 | 30.000 |
| L-Cysteine hydrochloride monohydrate | 7048-04-6 | 57.986 |
| L-Cystine dihydrochloride | 30925-07-6 | 26.070 |
| L-Glutamic acid | 56-86-0 | 44.500 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 16.409 |
| L-Isoleucine | 73-32-5 | 50.000 |
| L-Leucine | 61-90-5 | 75.000 |
| L-Lysine hydrochloride | 657-27-2 | 87.460 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 25.000 |
| L-Proline | 147-85-3 | 30.000 |
| L-Serine | 56-45-1 | 10.000 |
| L-Threonine | 72-19-5 | 40.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-45-6 | 50.650 |
| L-Valine | 72-18-4 | 50.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Alpha Tocopherol phosphate disodium salt | 60934-46-5 | 0.010 |
| Ascorbic acid sodium salt | 134-03-2 | 2.270 |
| Calciferol | 50-14-6 | 0.100 |
| Choline chloride | 67-48-1 | 1.500 |
| D-Biotin | 58-85-5 | 0.500 |
| D-Ca-Pantothenate hemicalcium | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Menadione sodium bisulfite | 130-37-0 | 0.010 |
| Niacinamide | 98-92-0 | 1.000 |
| Pyridoxine hydrochloride | 58-56-0 | 1.000 |
| Retinol acetate | 127-47-9 | 0.010 |
| Riboflavin | 83-88-5 | 0.010 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| Vitamin B12 | 68-19-9 | 0.200 |
| myo-Inositol | 87-89-8 | 2.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 2000.000 |
| Glutathione reduced | 70-18-8 | 0.050 |
| Methyl linoleate | 2777-58-4 | 0.030 |
| Phenol red sodium salt | 34487-61-1 | 10.700 |
| Sodium pyruvate | 113-24-6 | 25.000 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under an ISO 13485:2016-certified quality management system. Final QC at the Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm, with controlled trace metals and low organic carbon (TOC).
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending; Certificate of Analysis available for every lot.
Endotoxin — USP <85> BET
LAL assay; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL, tested per batch.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: Contact for specification.
Documentation & CoA
Full CoA with raw-material traceability available on request.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-WME1X compares
FluxMPS™ DCP-WME1X vs. conventional 0.22 µm–filtered William's formulations.
| Parameter | DCP-WME1X (FluxMPS™) | Conventional William's Medium (0.22 µm filtered) |
Standard DMEM/RPMI (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Standard grade | Standard grade |
| William's Medium E — methyl linoleate + glutathione for primary hepatocyte, liver-on-chip, and CYP450 OoC assays | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma barrier filtration | check_circle Yes (0.1 µm mycoplasma-retentive) | cancel No | cancel No |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes (Method 1) | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Available on request | cancel Fixed catalog SKU | cancel Fixed catalog SKU |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-WME1X — William's Medium E.
Supporting literature
Key publications supporting William's Medium E in hepatocyte culture and liver OoC applications.
- Williams GM, Gunn JM. Long-term cell culture of adult rat liver epithelial cells. Exp Cell Res. 1974;89:139–142. doi:10.1016/0014-4827(74)90201-8
- Guguen-Guillouzo C, Guillouzo A. General review on in vitro hepatocyte models. Methods Mol Biol. 2010;640:1–40. doi:10.1007/978-1-60761-688-7_1
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Kietzmann T. Metabolic zonation of the liver: the oxygen gradient revisited. Redox Biol. 2017;11:622–630. doi:10.1016/j.redox.2017.01.012
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j


